c-Rel phenocopies PKCθ but not Bcl-10 in regulating CD8+ T-cell activation versus tolerance

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 867-877

  Deenick, Elissa K ^a,b,f   Po, Leslie ^b   Chapatte, Laurence ^a,b   Murakami, Kiichi ^a,b   Lu, Yong Chen ^a,b   Elford, Alisha R ^a,b   Saibil, Samuel D ^a,b   Ruland, Jürgen ^c,d   Gerondakis, Steve ^e   Mak, Tak W ^a,b   Ohashi, Pamela S ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e BURNET INSTITUTE   (Australia)

^f GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Anergy; CD8+ T cells; NF B pathway; Tolerance

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 10; PROTEIN KINASE C THETA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT3; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CLONAL ANERGY; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; ISOENZYMES; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; NF-KAPPA B; PHENOTYPE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION;

EID: 77749245803     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939445     Document Type: Article

References (49)

1. Mondino, A. and Mueller, D. L., mTOR at the crossroads of T cell proliferation and tolerance. Semin. Immunol. 2007. 19: 162-172.
2. Saibil, S. D., Deenick, E. K. and Ohashi, P. S., The sound of silence: modulating anergy in T lymphocytes. Curr. Opin. Immunol. 2007. 19: 658-664.
3. Pfeifhofer, C., Kofler, K., Gruber, T., Tabrizi, N. G., Lutz, C., Maly, K., Leitges, M. and Baier, G., Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 2003. 197: 1525-1535.
4. Sun, Z., Arendt, C. W., Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J. et al., PKC-theta is required for TCR-induced NFkappaB activation in mature but not immature T lymphocytes. Nature 2000. 404: 402-407.
5. Altman, A., Isakov, N. and Baier, G., Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol. Today 2000. 21: 567-573.
6. Coudronniere, N., Villalba, M., Englund, N. and Altman, A., NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc. Natl. Acad. Sci. USA 2000. 97: 3394-3399.
7. Khoshnan, A., Bae, D., Tindell, C. A. and Nel, A. E., The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28. J. Immunol. 2000. 165: 6933-6940.
8. Huang, J., Lo, P. F., Zal, T., Gascoigne, N. R., Smith, B. A., Levin, S. D. and Grey, H. M., CD28 plays a critical role in the segregation of PKC theta within the immunologic synapse. Proc. Natl. Acad. Sci. USA 2002. 99: 9369-9373.
9. Bi, K., Tanaka, Y., Coudronniere, N., Sugie, K., Hong, S., van Stipdonk, M. J. and Altman, A., Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat. Immunol. 2001. 2: 556-563.
10. Sanchez-Lockhart, M., Graf, B. and Miller, J., Signals and sequences that control CD28 localization to the central region of the immunological synapse. J. Immunol. 2008. 181: 7639-7648.
11. Berg-Brown, N. N., Gronski,M. A., Jones, R. G., Elford, A. R., Deenick, E. K., Odermatt, B., Littman, D. R. and Ohashi, P. S., PKCtheta signals activation versus tolerance in vivo. J. Exp. Med. 2004. 199: 743-752.
12. Heissmeyer, V., Macian, F., Im, S. H., Varma, R., Feske, S., Venuprasad, K., Gu, H. et al., Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 2004. 5: 255-265.
13. Marsland, B. J., Nembrini, C., Schmitz, N., Abel, B., Krautwald, S., Bachmann, M. F. and Kopf,M., Innate signals compensate for the absence of PKC-theta during in vivo CD8(+) T cell effector and memory responses. Proc. Natl. Acad. Sci. USA 2005. 102: 14374-14379.
14. Thome, M., CARMA1, BCL-10 and MALT1 in lymphocyte development and activation. Nat. Rev. Immunol. 2004. 4: 348-359.
15. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. and Baltimore, D., Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995. 376: 167-170.
16. Doi, T. S., Takahashi, T., Taguchi, O., Azuma, T. and Obata, Y., NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 1997. 185: 953-961.
17. Horwitz, B. H., Scott, M. L., Cherry, S. R., Bronson, R. T. and Baltimore, D., Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells. Immunity 1997. 6: 765-772.
18. Kundig, T. M., Shahinian, A., Kawai, K., Mittrucker, H. W., Sebzda, E., Bachmann, M. F., Mak, T. W. and Ohashi, P. S., Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 1996. 5: 41-52.
19. Kontgen, F., Grumont, R. J., Strasser, A., Metcalf, D., Li, R., Tarlinton, D. and Gerondakis, S., Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 1995. 9: 1965-1977.
20. Strasser, A., Grumont, R. J., Stanley, M. L. and Gerondakis, S., The transcriptional regulator Rel is essential for antigen receptor-mediated stimulation of mature T cells but dispensable for positive and negative selection of thymocytes and T cell apoptosis. Eur. J. Immunol. 1999. 29: 928-935.
21. Liou, H. C., Jin, Z., Tumang, J., Andjelic, S., Smith, K. A. and Liou, M. L., c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 1999. 11: 361-371.
22. Carrasco, D., Cheng, J., Lewin, A., Warr, G., Yang, H., Rizzo, C., Rosas, F., Snapper, C. and Bravo, R., Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein. J. Exp. Med. 1998. 187: 973-984.
23. Zheng, Y., Ouaaz, F., Bruzzo, P., Singh, V., Gerondakis, S. and Beg, A. A., NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death. J. Immunol. 2001. 166: 4949-4957.
24. Kingeter, L. M. and Schaefer, B. C., Loss of protein kinase Ctheta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappaB activation in the CD4+ T cell subset. J. Immunol. 2008. 181: 6244-6254.
25. Hilliard, B. A., Mason, N., Xu, L., Sun, J., Lamhamedi-Cherradi, S. E., Liou, H. C., Hunter, C. and Chen, Y. H., Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 2002. 110: 843-850.
26. Mintern, J. D., Belz, G., Gerondakis, S., Carbone, F. R. and Heath, W. R., The cross-priming APC requires a Rel-dependent signal to induce CTL. J. Immunol. 2002. 168: 3283-3287.
27. Boffa, D. J., Feng, B., Sharma, V., Dematteo, R., Miller, G., Suthanthiran, M., Nunez, R. and Liou, H. C., Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. Cell Immunol. 2003. 222: 105-115.
28. Mason, N. J., Liou, H. C. and Hunter, C. A., T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. J. Immunol. 2004. 172: 3704-3711.
29. Ouaaz, F., Arron, J., Zheng, Y., Choi, Y. and Beg, A. A., Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002. 16: 257-270.
30. Manicassamy, S., Gupta, S., Huang, Z. and Sun, Z., Protein Kinase C-theta-Mediated Signals Enhance CD4+ T Cell Survival by Up-Regulating Bcl-xL. J. Immunol. 2006. 176: 6709-6716.
31. Barouch-Bentov, R., Lemmens, E. E., Hu, J., Janssen, E. M., Droin, N. M., Song, J., Schoenberger, S. P. and Altman, A., Protein kinase C-theta is an early survival factor required for differentiation of effector CD8+ T cells. J. Immunol. 2005. 175: 5126-5134.
32. Saibil, S. D., Jones, R. G., Deenick, E. K., Liadis, N., Elford, A. R., Vainberg, M. G., Baerg, H. et al., CD4+ and CD8+ T cell survival is regulated differentially by PKC-theta, c-rel and PKB. J. Immunol. 2007. 178: 2932-2939.
33. Zhou, P., Balin, S. J., Mashayekhi, M., Hwang, K. W., Palucki, D. A. and Alegre, M. L., Transplantation tolerance in NF-kappaB-impaired mice is not due to regulation but is prevented by transgenic expression of Bcl-xL. J. Immunol. 2005. 174: 3447-3453.
34. Wells, A. D., Li, X. C., Li, Y., Walsh, M. C., Zheng, X. X., Wu, Z., Nunez, G. et al., Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat. Med. 1999. 5: 1303-1307.
35. Macian, F., Garcia-Cozar, F., Im, S. H., Horton, H. F., Byrne, M. C. and Rao, A., Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002. 109: 719-731.
36. Soto-Nieves, N., Puga, I., Abe, B. T., Bandyopadhyay, S., Baine, I., Rao, A. and Macian, F., Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J. Exp. Med. 2009. 206: 867-876.
37. Campbell, I. K., Gerondakis, S., O'Donnell, K. and Wicks, I. P., Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J. Clin. Invest. 2000. 105: 1799-1806.
38. Jones, R. G., Saibil, S. D., Pun, J. M., Elford, A. R., Bonnard, M., Pellegrini, M., Arya, S. et al., NF-κB couples protein kinase B/Akt signaling to distinct survival pathways and the regulation of lymphocyte homeostasis in vivo. J. Immunol. 2005. 175: 3790-3799.
39. O'Keeffe, M., Grumont, R. J., Hochrein, H., Fuchsberger, M., Gugasyan, R., Vremec, D., Shortman, K. and Gerondakis, S., Distinct roles for the NFkappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 2005. 106: 3457-3464.
40. Hayden, M. S. and Ghosh, S., Signaling to NF-kappaB. Genes Dev. 2004. 18: 2195-2224.
41. Ruland, J., Duncan, G. S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D. G. et al., Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 2001. 104: 33-42.
42. Narayan, P., Holt, B., Tosti, R. and Kane, L. P., CARMA1 is required for Aktmediated NF-kappaB activation in T cells. Mol. Cell Biol. 2006. 26: 2327-2336.
43. Rueda, D., Gaide, O., Ho, L., Lewkowicz, E., Niedergang, F., Hailfinger, S., Rebeaud, F. et al., Bcl10 controls TCR- and FcgammaR-induced actin polymerization. J. Immunol. 2007. 178: 4373-4384.
44. Banerjee, D., Liou, H. C. and Sen, R., c-Rel-dependent priming of naive T cells by inflammatory cytokines. Immunity 2005. 23: 445-458.
45. Kalli, K., Huntoon, C., Bell, M. and McKean, D. J., Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptorinitiated regulation of IL-2 gene expression by NF-kappaB. Mol. Cell Biol. 1998. 18: 3140-3148.
46. Zhou, X. Y., Yashiro-Ohtani, Y., Nakahira, M., Park, W. R., Abe, R., Hamaoka, T., Naramura, M. et al., Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J. Immunol. 2002. 168: 3847-3854.
47. Pircher, H., Burki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M., Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989. 342: 559-561.
48. Sha, W. C., Liou, H. C., Tuomanen, E. I. and Baltimore, D., Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995. 80: 321-330.
49. Chao, D. T., Linette, G. P., Boise, L. H., White, L. S., Thompson, C. B. and Korsmeyer, S. J., Bcl-XL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 1995. 182: 821-828.